SECuRE update: recruitment target of the Cohort Expansion Main Group achieved

Data ReadoutPositive

AI Analysis

Summary

Clarity Pharmaceuticals announced achievement of recruitment targets for the Cohort Expansion Main Group in the SECuRE clinical trial. The company is a clinical-stage radiopharmaceutical developer focused on cancer treatment solutions.

Clinical Trial Data

Outcome Details

Recruitment target of the Cohort Expansion Main Group achieved in SECuRE study

Importance:4/10

Sentiment:

0.50

Clinical TrialRadiopharmaceuticalOncologyPatient Recruitment

Related Companies

$GBIO $CBDY

Read the original article

Published by PR Newswire Biotech on October 8, 2026 1:01 PM

Read Original